Fate Therapeutics Statistics

Total Valuation

FATE has a market cap or net worth of $185.08 million. The enterprise value is -$8.88 million.

Market Cap	185.08M
Enterprise Value	-8.88M

Important Dates

The next estimated earnings date is Monday, February 24, 2025, after market close.

Earnings Date	Feb 24, 2025
Ex-Dividend Date	n/a

Share Statistics

FATE has 113.89 million shares outstanding. The number of shares has increased by 11.03% in one year.

Current Share Class	113.89M
Shares Outstanding	113.89M
Shares Change (YoY)	+11.03%
Shares Change (QoQ)	+0.26%
Owned by Insiders (%)	1.70%
Owned by Institutions (%)	89.87%
Float	99.13M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	13.44
Forward PS	35.65
PB Ratio	0.52
P/TBV Ratio	0.52
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.29, with a Debt / Equity ratio of 0.27.

Current Ratio	8.29
Quick Ratio	8.10
Debt / Equity	0.27
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -46.59% and return on invested capital (ROIC) is -23.70%.

Return on Equity (ROE)	-46.59%
Return on Assets (ROA)	-22.11%
Return on Capital (ROIC)	-23.70%
Revenue Per Employee	$74,293
Profits Per Employee	-$984,702
Employee Count	181
Asset Turnover	0.03
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -53.05% in the last 52 weeks. The beta is 1.93, so FATE's price volatility has been higher than the market average.

Beta (5Y)	1.93
52-Week Price Change	-53.05%
50-Day Moving Average	2.44
200-Day Moving Average	3.84
Relative Strength Index (RSI)	34.26
Average Volume (20 Days)	3,576,956

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FATE had revenue of $13.45 million and -$178.23 million in losses. Loss per share was -$1.64.

Revenue	13.45M
Gross Profit	-108.86M
Operating Income	-183.70M
Pretax Income	-190.05M
Net Income	-178.23M
EBITDA	-164.67M
EBIT	-183.70M
Loss Per Share	-$1.64

Full Income Statement

Balance Sheet

The company has $296.92 million in cash and $98.98 million in debt, giving a net cash position of $197.95 million or $1.74 per share.

Cash & Cash Equivalents	296.92M
Total Debt	98.98M
Net Cash	197.95M
Net Cash Per Share	$1.74
Equity (Book Value)	362.33M
Book Value Per Share	3.18
Working Capital	272.87M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$131.71 million and capital expenditures -$813,000, giving a free cash flow of -$132.52 million.

Operating Cash Flow	-131.71M
Capital Expenditures	-813,000
Free Cash Flow	-132.52M
FCF Per Share	-$1.16

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-1,366.13%
Pretax Margin	-1,325.43%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

FATE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-11.03%
Shareholder Yield	-11.03%
Earnings Yield	-94.27%
FCF Yield	-70.10%

Analyst Forecast

The average price target for FATE is $6.75, which is 315.39% higher than the current price. The consensus rating is "Hold".

Price Target	$6.75
Price Target Difference	315.39%
Analyst Consensus	Hold
Analyst Count	10
Revenue Growth Forecast (5Y)	10.80%
EPS Growth Forecast (5Y)	-18.83%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FATE has an Altman Z-Score of -2.32 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.32
Piotroski F-Score	1